
IVBT
Financial Services · Shell Companies · $4,494 market cap
$0.00020.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 6, 2025 | Time not confirmed | — | -0.05 | — |
| Jan 27, 2025 | Time not confirmed | — | -0.02 | — |
| Dec 15, 2022 | Time not confirmed | — | -2.46 | — |
| Jul 14, 2022 | Time not confirmed | — | -0.09 | — |
| Apr 15, 2022 | Time not confirmed | — | -0.09 | — |
| Jan 19, 2022 | Time not confirmed | — | -0.04 | — |
| Jul 13, 2021 | Time not confirmed | — | 4.22 | — |
| Apr 14, 2021 | Time not confirmed | — | 2.97 | — |
| Dec 15, 2020 | Time not confirmed | — | -0.02 | — |
| Jul 20, 2020 | Time not confirmed | — | 0.29 | — |
| Apr 20, 2020 | Time not confirmed | — | -0.01 | — |
| Dec 17, 2019 | Time not confirmed | — | -0.61 | — |
| Jul 18, 2019 | Time not confirmed | — | -0.05 | — |
Innovation1 Biotech Inc. focuses on researching, developing, producing, and selling pharmaceutical products. The company offers natural supplements for the treatment of symptoms associated with the flu and long covid under the NutraFlu and Nutravid19 brands; and other supplement and medical nutrition products. It also develops NLC001 that is in Phase II clinical trial for the treatment of long covid and other viral…
| Time not confirmed |
| — |
| 0.03 |
| — |
| Jan 18, 2019 | Time not confirmed | — | -0.01 | — |
| Jul 23, 2018 | Time not confirmed | — | -0.04 | — |
| Apr 23, 2018 | Time not confirmed | — | -0.28 | — |
| Jan 22, 2018 | Time not confirmed | — | -0.07 | — |